Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Moeller, Miriam ^a   Thonig, Antje ^a   Pohl, Sabine ^a   Ripoll, Cristina ^a   Zipprich, Alexander ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METHOXAMINE; N(G) METHYLARGININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HEPATIC ARTERIAL VASODILATION; IMMUNOHISTOCHEMISTRY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER ISCHEMIA; LIVER PERFUSION; LIVER SINUSOID; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PROTEIN EXPRESSION; RAT; VASOCONSTRICTION; VEIN RESISTANCE; WESTERN BLOTTING; ANIMAL; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; HEPATIC ARTERY; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; VASCULAR RESISTANCE; VASODILATATION; WISTAR RAT;

ANIMALIA;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATIC ARTERY; HYPERTENSION, PORTAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; METHOXAMINE; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; PERFUSION; RATS, WISTAR; VASCULAR RESISTANCE; VASODILATION;

EID: 84925879130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121229     Document Type: Article

References (27)

1. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249:G549-56. PMID: 3904482
2. Lautt WW, Lautt WW, Legare DJ, Legare DJ, d'Almeida MS, d'Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol 1985.
3. Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996; 74:223-33. PMID: 8773400
4. Richter S, Mücke I, Mücke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000; 279:G454-62. PMID: 10915656
5. Richter S, Olinger A, Hildebrandt U, Menger MD, Vollmar B. Loss of physiologic hepatic blood flow control ("hepatic arterial buffer response") during CO2-pneumoperitoneum in the rat. Anesth Analg 2001; 93:872-7. PMID: 11574348
6. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis - a histological classification of the severity of cirrhosis. Journal of Hepatology 2006; 44:111-7. PMID: 16274836
7. Iwakiri Y, Grisham M, Shah V. Vascular biology and pathobiology of the liver: Report of a single-topic symposium. Hepatology 2008; 47:1754-63. doi: 10.1002/hep.22203 PMID: 18393322
8. Zipprich A. Hemodynamics in the isolated cirrhotic liver. J Clin Gastroenterol 2007; 41 Suppl 3:S254-8. PMID: 17975473
9. Zipprich A, Loureiro-Silva MR, D'Silva I, Groszmann RJ. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver. 2008; 295:G197-G202. doi: 10.1152/ajpgi.00190.2007 PMID: 18497333
10. Zipprich A, Loureiro-Silva MR, Jain D, D'Silva I, Groszmann RJ. Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver. Journal of Hepatology 2008; 49:739-45. doi: 10.1016/j.jhep.2008.06.027 PMID: 18804307
11. Zipprich A, Mehal WZ, Ripoll C, Groszmann RJ. A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver. Liver Int 2010; 30:988-94. doi: 10.1111/j.1478-3231.2010.02278.x PMID: 20500549
12. Corpechot C. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002; 35:1010-21. PMID: 11981751
13. Kleber G, Steudel N, Behrmann C, Zipprich A, Hübner G, Lotterer E, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: Use of intra-arterial Doppler and adenosine infusion. Gastroenterology 1999; 116:906-14. PMID: 10092313
14. Zipprich A, Steudel N, Behrmann C, Meiss F, Sziegoleit U, Fleig WE, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 2003; 37:385-92. PMID: 12540789
15. Fondevila C, Hessheimer AJ, Taurá P, Sánchez O, Calatayud D, de Riva N, et al. Portal hyperperfusion: mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation. Liver Transpl 2010; 16:364-74. doi: 10.1002/lt.21989 PMID: 20209596
16. Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 2006; 30:986-93. PMID: 16861970
17. Smyrniotis V, Kostopanagiotou G, Kondi A, Gamaletsos E, Theodoraki K, Kehagias D, et al. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int 2002; 15:355-60. PMID: 12122512
18. Lautt WW, Legare DJ, Ezzat WR. Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology 1990; 98:1024-8. PMID: 2311859
19. Richter S, Vollmar B, Mücke I, Mücke I, Post S, Menger MD. Hepatic arteriolo-portal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. The Journal of Physiology 2001; 531:193-201. PMID: 11179403
20. Mucke I, Richter S, Menger MD, Vollmar B. Significance of hepatic arterial responsiveness for adequate tissue oxygenation upon portal vein occlusion in cirrhotic livers. International Journal of Colorectal Disease 2000; 15:335-41. PMID: 11151440
21. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J, et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. The American Journal of Pathology 1999; 155:1065-73. PMID: 10514389
22. James PE, Madhani M, Roebuck W, Jackson SK, Swartz HM. Endotoxin-Induced Liver Hypoxia: Defective Oxygen Delivery versus Oxygen Consumption. Nitric Oxide 2002; 6:18-28. PMID: 11829531
23. Cejudo-Martín P. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 2002; 36:1172-9. PMID: 12395327
24. El-Desoky AEH, Jiao LR, Havlik R, Habib N, Davidson BR, Seifalian AM. Measurement of Hepatic Tissue Hypoxia Using Near Infrared Spectroscopy: Comparison with Hepatic Vein Oxygen Partial Pressure. Eur Surg Res 2000; 32:207-14. PMID: 11014921
25. Sohail MA, Hashmi AZ, Hakim W, Watanabe A, Zipprich A, Groszmann RJ, et al. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 2009; 49:185-94. doi: 10.1002/hep.22589 PMID: 18844235
26. Gracia-Sancho J, Russo L, Garcia-Caldero H, Garcia-Pagan JC, Garcia-Cardena G, Bosch J. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut 2011; 60:517-24. doi: 10.1136/gut.2010.220913 PMID: 21112949
27. Marrone G, Russo L, Rosado E, Hide D, García-Cardeña G, Garcia-Pagan JC, et al. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. Journal of Hepatology 2013; 58:98-103. doi: 10.1016/j.jhep.2012.08.026 PMID: 22989565